Keystone Symposia

This meeting took place in 2020


Here are the related meetings in 2022:
Emerging Cellular Therapies (Q6)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Emerging Cellular Therapies: Cancer and Beyond (Q1)


Organizer(s) Crystal L. Mackall, Marina Cavazzana and Stanley R. Riddell
February 8—12, 2020
Fairmont Banff Springs • Banff, AB Canada
Discounted Abstract Deadline: Oct 29, 2019
Abstract Deadline: Nov 6, 2019
Scholarship Deadline: Oct 29, 2019
Discounted Registration Deadline: Dec 10, 2019

Sponsored by BioLegend, Inc., Novo Nordisk A/S, Roche and TCR² Therapeutics


Summary of Meeting:
After many years of fundamental research, cell-based therapies are now recognized as effective medicines for treatment of a specific subset of cancers as well as a growing list of autoimmune, degenerative and infectious diseases. This clinical progress has been propelled by exponential growth in understanding of the underlying cell biology, and increasingly sophisticated techniques for genetic engineering and for using synthetic biology to control cellular therapeutics. Cellular therapeutics are now poised for increasing impact both in cancer medicine and in the treatment of genetic, autoimmune and degenerative diseases. This conference will bring together fundamental researchers and translational scientists to discuss recent successes and highlight challenges across the spectrum of emerging cellular therapeutics. Another innovative aspect of this conference is the joint pairing with the Keystone Symposia conference on “Engineering the Genome” organized by Drs. Vic Myer and Erik Sontheimer. This unique pairing will provide an outstanding opportunity to cross-fertilize ideas and to facilitate formation of new collaborations between experts in genome engineering and experts in cell biology, cell-based therapies and synthetic biology. The conference will provide an opportunity to report emerging preclinical and clinical insights, present novel platforms, and highlight challenges related to both safety and efficacy of cell therapies. The broad disease focus will enhance collaborations between the cancer immunotherapy communities and those focused on developing cell therapies for non-malignant disease.

View Meeting Program

Scholarships/Awards


Keystone Symposia Future of Science Fund Scholarship Recipients


Charlotte U. Brey
Children's Cancer Research Institute, Austria

National Cancer Institute (NCI) Scholarship Recipients


H. Kay Chung
The Salk Institute for Biological Studies, USA

Michela Consonni
Fondazione Centro San Raffaele, Italy

Brian Koss
University of Arkansas for Medical Sciences, USA

Brooke Prinzing
St. Jude Children's Research Hospital, USA

Connor A. Tsuchida
University of California, Berkeley; University of California, San Francisco, USA

Linda T. Vo
University of California, San Francisco, USA